These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10500980)

  • 1. [Progress in developing viral polynucleotide (DNA) vaccines].
    Gendon IuZ
    Vopr Virusol; 1999; 44(4):148-54. PubMed ID: 10500980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvants for foot-and-mouth disease virus vaccines: recent progress.
    Cao Y
    Expert Rev Vaccines; 2014 Nov; 13(11):1377-85. PubMed ID: 25234962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucosal viral vaccines: progress and problems].
    Gendon IuZ
    Vopr Virusol; 2003; 48(4):4-10. PubMed ID: 12945199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract.
    Chen L; Lin T; Zhang H; Su Y
    Intervirology; 2005; 48(4):207-12. PubMed ID: 15920343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccines: developing new strategies to enhance immune responses.
    Abdulhaqq SA; Weiner DB
    Immunol Res; 2008; 42(1-3):219-32. PubMed ID: 19066740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The adjuvant effect of granulocyte macrophage colony stimulating factor (GM-CSF) in dengue virus and hepatitis C virus DNA vaccines].
    Wu JM; Chen H; Sheng ZY; Wang J; Fan DY; Gao N; An J
    Bing Du Xue Bao; 2012 May; 28(3):207-12. PubMed ID: 22764521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of DNA vaccines against foot-and-mouth disease.
    Fowler VL; Barnett PV
    Expert Rev Vaccines; 2012 Apr; 11(4):481-93. PubMed ID: 22551033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines.
    Sullivan SM; Doukas J; Hartikka J; Smith L; Rolland A
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1433-46. PubMed ID: 21118032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant activity of fish type I interferon shown in a virus DNA vaccination model.
    Chang CJ; Sun B; Robertsen B
    Vaccine; 2015 May; 33(21):2442-8. PubMed ID: 25865470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.).
    Xu C; Mutoloki S; Evensen Ø
    Vaccine; 2012 Jun; 30(26):3918-28. PubMed ID: 22504037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharides against Viruses: Immunostimulatory Properties and the Delivery of Antiviral Vaccines and Drugs.
    Junter GA; Karakasyan C
    Crit Rev Ther Drug Carrier Syst; 2020; 37(1):1-64. PubMed ID: 32450013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P; Jacob Y; Desmézières E; Tordo N
    Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vaccines for bony fish: past, present and future.
    Salgado-Miranda C; Loza-Rubio E; Rojas-Anaya E; García-Espinosa G
    Expert Rev Vaccines; 2013 May; 12(5):567-78. PubMed ID: 23659303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Avian influenza vaccines].
    Vasil'ev IuM
    Vopr Virusol; 2008; 53(6):4-15. PubMed ID: 19172900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving DNA vaccines targeting viral infection.
    Sin JI; Weiner DB
    Intervirology; 2000; 43(4-6):233-46. PubMed ID: 11251379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
    Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vectors for use in the development of biodefense vaccines.
    Lee JS; Hadjipanayis AG; Parker MD
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.